Biocon Biologics refinances $1.1 bn long-term debt via bonds, new facility
Biocon Biologics has secured a new syndicated debt facility through a commitment agreement. Photo: X@BioconBiologics 2 min read Last Updated
Continue reading
Tag: Biocon Biologics
Biocon inks pact with Janssen to commercialise biosimilar products in Japan
Biocon Biologics had earlier announced a settlement agreement in the US for Bmab 1200 launch no later than February 22,
Continue reading
Biocon subsidiary partners with Sandoz Australia
Biocon’s subsidiary, Biocon Biologics Ltd (BBL), a fully integrated biosimilar company, has announced a five-year partnership with Sandoz AG (Sandoz).
Continue reading
Biocon Biologics integrates Viatris’ biosimilar Filesadmin.co in 31 European nations
Biocon Biologics on Thursday said it has completed the integration of the acquired biosimilar business from Viatris Inc in
Continue reading
Biosimilars growth props up Biocon Q2 PAT by 168% to Rs 126 crore
Biologics major Bengaluru-based Biocon posted a 168 per cent year-on-year rise in its consolidated net profit for the September
Continue reading
Share Market Highlights 20 October 2023: Sensex sheds 250 pts, Nifty below 19,600; Nestle India, TCS shine; ITC, HUL shed
On October 20, the Sensex and Nifty indices are poised to commence trading on a cautious note, as per indications
Continue reading
Stock Market Live Updates on October 19, 2023: Gift Nifty indicates 100 pts gap-down opening for Nifty
tock Market today | Share Market Live Updates – Find here all the live updates related to Sensex, Nifty, BSE,
Continue reading